Rubius Therapeutics Shares 2011-2026 | RUBY

Annual Shares Rubius Therapeutics

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
90.3 M	88 M	80.6 M	78.7 M	39.3 M	45.7 M	8.54 M	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
90.3 M	8.54 M	61.6 M

Quarterly Shares Rubius Therapeutics

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	90.4 M	90.3 M	90.1 M	90.1 M	89.8 M	89.5 M	82.3 M	81.1 M	80.8 M	80.5 M	80.3 M	80 M	79.1 M	78.4 M	77.5 M	79.2 M	62.3 M	8.73 M	8.36 M	15 M	8.08 M	7.87 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
90.4 M	7.87 M	65.9 M

Shares of other stocks in the Biotechnology industry

Issuer	Shares	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	38.7 M	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	33.4 M	-	2.43 %	$ 254 M	Germany
MannKind Corporation MNKD	306 M	$ 3.56	24.48 %	$ 1.09 B	USA
AgeX Therapeutics AGE	10.2 M	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	220 M	-	-	$ 866 M	China
Bio-Techne Corporation TECH	158 M	$ 47.41	-16.36 %	$ 7.47 B	USA
United Therapeutics Corporation UTHR	44.3 M	$ 596.76	4.29 %	$ 26.4 B	USA
Midatech Pharma plc MTP	80.5 M	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	219 M	-	-	$ 40.3 B	USA
Biophytis SA BPTS	118 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	44.7 B	-	2.54 %	$ 160 B	France
EyeGate Pharmaceuticals, Inc. EYEG	4.58 M	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	4.28 M	-	-	$ 269 M	USA
BioNTech SE BNTX	244 M	-	-	$ 27.2 B	Germany
Институт стволовых клеток человека ISKJ	75 M	-	-	-	Russia
Checkmate Pharmaceuticals CMPI	21.6 M	-	-	$ 231 M	USA
INmune Bio INMB	24.8 M	$ 1.52	-1.3 %	$ 37.6 M	USA
Exelixis EXEL	272 M	$ 48.7	9.64 %	$ 13.2 B	USA
ACADIA Pharmaceuticals ACAD	166 M	$ 21.48	-3.89 %	$ 3.56 B	USA
Fortress Biotech FBIO	27.9 M	-	-	$ 71.1 M	USA
Advaxis ADXS	6.02 M	-	-9.65 %	$ 45.9 M	USA
Esperion Therapeutics ESPR	208 M	$ 3.15	1.19 %	$ 655 M	USA
Can-Fite BioPharma Ltd. CANF	1.65 M	-	-	$ 5.51 M	Israel
Aeterna Zentaris AEZS	115 M	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	78.2 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	186 M	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	45 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	14.3 M	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	67.1 M	-	-	$ 3.67 B	USA
Aptose Biosciences APTO	2.45 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	67.7 M	-	-39.0 %	$ 4.57 M	USA
Akouos AKUS	34.4 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	19.2 M	-	-0.23 %	$ 916 M	USA
Allakos ALLK	86.8 M	-	-	$ 28.6 M	USA
AlloVir ALVR	15.3 M	-	4.14 %	$ 49.1 M	USA
Arcutis Biotherapeutics ARQT	127 M	$ 24.17	3.2 %	$ 3.08 B	USA
Allena Pharmaceuticals ALNA	68 M	-	3.16 %	$ 1.9 M	USA
Ampio Pharmaceuticals AMPE	810 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	38.8 M	-	-	$ 10.1 M	USA
Alpine Immune Sciences ALPN	33.4 M	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	25.4 M	-	10.36 %	$ 9.8 M	USA
Applied Therapeutics APLT	84.2 M	-	-	$ 8.42 M	USA
Aravive ARAV	36.4 M	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	18.8 M	-	17.91 %	$ 11.1 M	USA
CRISPR Therapeutics AG CRSP	89.9 M	$ 55.08	5.15 %	$ 4.95 B	Schweiz
Avenue Therapeutics ATXI	3.13 M	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	266 M	$ 1.7	3.66 %	$ 452 M	Britain
AVROBIO AVRO	44.3 M	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	15.4 M	-	-	$ 7.46 M	Israel
Завод ДИОД DIOD	91.5 M	-	-	-	Russia